Hepatoprotective Effect of Jianpi Huoxue Formula on Nonalcoholic Fatty Liver Disease Induced by Methionine-Choline-Deficient Diet in Rat.

In parallel with the prevalence metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in most countries. It features a constellation of simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and even hepatocellular carcinom...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International pp. 1 - 13
Autores principales: Feng, Yu, Chen, Yan, Yang, Binrui, Lan, Qingping, Wang, Tao, Cui, Guozhen, Ren, Zhitao, Choi, I. Cheong, Leung, George Pak-Heng, Yan, Fenggen, Chen, Dacan, Yu, Hon Ho, Lee, Simon Ming Yuen
Formato: pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell 7/1/2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137262544&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 137262544
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 7/1/2019
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        137262544
        137262544
        137262544
        10.1155/2019/7465272
        137262544
      ppf: 1
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Hepatoprotective Effect of Jianpi Huoxue Formula on Nonalcoholic Fatty Liver Disease Induced by Methionine-Choline-Deficient Diet in Rat.
      aug:
        au:
          Feng, Yu
          Chen, Yan
          Yang, Binrui
          Lan, Qingping
          Wang, Tao
          Cui, Guozhen
          Ren, Zhitao
          Choi, I. Cheong
          Leung, George Pak-Heng
          Yan, Fenggen
          Chen, Dacan
          Yu, Hon Ho
          Lee, Simon Ming Yuen
        affil: State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau
      sug:
        subj:
          Medicine, Chinese Traditional
          Drugs, Chinese Herbal Pharmacodynamics
          Liver Drug Effects
          Nonalcoholic Fatty Liver Disease Prevention and Control
          Methionine Deficiency
          Vitamin B Deficiency
          Diet
          Animal Studies
          Rats
          Choline
          Drugs, Chinese Herbal Administration and Dosage
          Administration, Oral
          Liver Diseases
          Lipids Blood
          Inflammation
          Fibrosis
          Apoptosis Drug Effects
          Alanine Aminotransferase Drug Effects
          Aspartate Aminotransferase Drug Effects
          Triglycerides Drug Effects
          Cholesterol Drug Effects
          Histological Techniques
          Disease Attributes
          Tumor Necrosis Factor Drug Effects
          Collagen Drug Effects
          Matrix Metalloproteinases Drug Effects
          Staining and Labeling Methods
          Caspases Drug Effects
      ab: In parallel with the prevalence metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in most countries. It features a constellation of simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and even hepatocellular carcinoma. There are no approved drugs for effective management of NAFLD and NASH. Jianpi Huoxue formula (JPHX) mainly consists of Atractylodes macrocephal (Baizhu), Salvia miltiorrhiza (Danshen), Rasux Paeonia Alba (Baishao), Rhizoma Alismatis (Zexie), and Fructus Schisandrae Chinensis (Wuweizi), which may have beneficial effects on NAFLD. The aim of the study was to identify the effect of JPHX on NAFLD. A NAFLD model was induced by methionine-choline-deficient food (MCD) in Wistar rats and orally administered with simultaneous JPHX, once a day for 8 weeks. Hepatocellular injury, lipid profile, inflammation, fibrosis, and apoptosis were evaluated. The results showed that JPHX significantly decreased the abnormal serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels compared with the MCD model (P<0.05). Furthermore, JPHX protected MCD diet-fed rats from accumulation of hepatic triglycerides (TG) and total cholesterol (TC). Histological examination demonstrated that JPHX noticeably normalized the NAFLD activity score (NAS). Moreover, JPHX ameliorated liver inflammation by decreasing TNF-α levels and reduced collagen and matrix metalloproteinases in MCD diet-fed rats. In addition, JPHX prevented rats from MCD-induced cellular apoptosis, as suggested by TUNEL staining, and suppressed the activation of caspase 3 and 7 proteins. JPHX also inhibited the phosphorylation of JNK. In conclusion, JPHX exhibited a hepatoprotective effect against NAFLD in an MCD experimental model.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N